Cilnidipine represents a significant development in the field of hypertension management, offering a dual mechanism of action through its inhibition of both L-type and N-type calcium channels. This unique profile allows it to not only lower blood pressure effectively but also suppress sympathetic nerve activity, which may contribute to improved cardiovascular outcomes.
San Lwin Trading was proud to host “Innovations in Hypertension Therapy,” a dedicated symposium held at the Novotel Hotel on May 18, 2025. The event provided a platform for healthcare professionals to delve into the clinical profile and emerging applications of Cilnidipine.
